The Dividend History page provides a single page to review all of the aggregated Dividend payment information. Visit our Dividend Calendar: Please note that the dividend history for Nasdaq stocks may ...

Drug maker Alumis (ALMS) is climbing 7% after investment bank Oppenheimer started coverage of the name with an Outperform rating. Why Oppenheimer Is Bullish on ALMS Due to concerns about Alumis’ cash ...

Fintel reports that on March 11, 2026, Raymond James initiated coverage of Alumis (NasdaqGS:ALMS) with a Strong Buy recommendation. Analyst Price Forecast Suggests 37.80% Upside As of February 26, ...

We recently published a list of Thursday’s 10 Worst-Performing Stocks. In this article, we are going to take a look at where Alumis Inc. (NASDAQ:ALMS) stands against other Thursday’s worst-performing ...